Previous close | 0.7850 |
Open | 0.7850 |
Bid | 0.7550 x 334700 |
Ask | 0.7700 x 1317400 |
Day's range | 0.7550 - 0.8000 |
52-week range | 0.7250 - 1.8400 |
Volume | |
Avg. volume | 396,750 |
Market cap | 307.62M |
Beta (5Y monthly) | 1.40 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.0440 |
Earnings date | 24 Aug 2022 - 29 Aug 2022 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | 25 Mar 1988 |
1y target est | N/A |
The big shareholder groups in Starpharma Holdings Limited ( ASX:SPL ) have power over the company. Insiders often own a...
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
In a major development for its VIRALEZE™ antiviral nasal spray, Starpharma (ASX: SPL) today announced that its potent antiviral agent, SPL7013, achieved the maximum possible virucidal effect against the highly transmissible Omicron variant of SARS-CoV-2.